BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug.
Fujimoto T, Teraishi F, Kanehira N, Tajima T, Sakurai Y, Kondo N, Yamagami M, Kuwada A, Morihara A, Kitamatsu M, Fujimura A, Suzuki M, Takaguchi Y, Shigeyasu K, Fujiwara T, Michiue H.
Fujimoto T, et al.
Biomaterials. 2024 May 9;309:122605. doi: 10.1016/j.biomaterials.2024.122605. Online ahead of print.
Biomaterials. 2024.
PMID: 38754291